Antithrombotiques et gestes invasifsMOTTIER, Dominique.MT. Médecine thérapeutique. 2007, Vol 12, issn 1264-6520, 80 p., NSSerial Issue

Treatment of Venous ThromboembolismMERLI, Geno J.The American journal of medicine. 2008, Vol 121, Num 11A, issn 0002-9343, S2-S9, SUPConference Paper

Treatment of Venous ThromboembolismWELLS, Philip S; FORGIE, Melissa A; RODGER, Marc A et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 7, pp 717-728, issn 0098-7484, 12 p.Article

LXR as a novel antithrombotic targetSPYRIDON, Michael; MORAES, Leonardo A; JONES, Chris I et al.Blood. 2011, Vol 117, Num 21, pp 5751-5761, issn 0006-4971, 11 p.Article

New Antithrombotic DrugsGROSS, P. L; WEITZ, J. I.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 2, pp 139-146, issn 0009-9236, 8 p.Article

Les antithrombotiques : Tradition et innovationHAINAUT, Ph.Louvain médical. 2005, Vol 124, Num 9, pp S176-S179, issn 0024-6956Conference Paper

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 updateCUISSET, Thomas; VALGIMIGIL, Marco; MUDRA, Harald et al.EuroIntervention. 2010, Vol 6, Num 1, pp 39-45, issn 1774-024X, 7 p.Article

Hémostase Le point sur les nouveaux antithrombotiques : Nouveautés en médecine 2009: deuxième partie = Update on new antithrombotic treatmentsBOEHLEN, F; TIREFORT-DIMITROVA, Y; DE MOERLOOSE, P et al.Revue médicale suisse. 2010, Vol 6, Num 232, pp 109-112, issn 1660-9379, 4 p.Article

Apixaban for Extended Treatment of Venous ThromboembolismAGNELLI, Giancarlo; BULLER, Harry R; COHEN, Alexander et al.The New England journal of medicine. 2013, Vol 368, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

Pregnancy-Associated Venous Thromboembolism: Prevention and TreatmentBATES, Shannon M.Seminars in hematology. 2011, Vol 48, Num 4, pp 271-284, issn 0037-1963, 14 p.Article

Dabigatran Etexilate: Clinical Implications in Dermatologic SurgeryBOTA, James P; LEBLANC, Keith G; SHEEHAN, Daniel J et al.Dermatologic surgery. 2012, Vol 38, Num 4, pp 675-676, issn 1076-0512, 2 p.Article

Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery : management strategiesROSENCHER, N; BONNET, M.-P; SESSLER, D. I et al.Anaesthesia. 2007, Vol 62, Num 11, pp 1154-1160, issn 0003-2409, 7 p.Article

Monitoring the new antithrombotic drugsWALENGA, Jeanine M; HOPPENSTEADT, Debra A.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 683-695, issn 0094-6176, 13 p.Conference Paper

New Antithrombotic Drugs: Potential for Use in OncologyLEVINE, Mark N.Journal of clinical oncology. 2009, Vol 27, Num 29, pp 4912-4918, issn 0732-183X, 7 p.Article

Cibles des médicaments antithrombotiques = Targets of antithrombotic drugsDROUET, Ludovic; RIPOLL, Laurent.MS. Médecine sciences. 2006, Vol 22, Num 10, pp 887-892, issn 0767-0974, 6 p.Article

Optimisation of the assa\ys for the measurement of clotting factor activity in the presence of rivaroxabanGEROTZIAFAS, Grigoris T; BACCOUCHE, Hela; SASSI, Mouna et al.Thrombosis research. 2012, Vol 129, Num 1, pp 101-103, issn 0049-3848, 3 p.Article

Rivaroxaban: un anti-thrombotique original : FA, CA, anti-thrombotiques: les grandes communications: SYMPOSIUMS DES LABORATOIRES BAYER HEALTHCARE PHARMACEUTICALKEVORKIAN, J.-P; CALLIF, R; ALEXANDER, J et al.Archives des maladies du coeur et des vaisseaux. Pratique. 2012, Num FEV, pp 13-15, issn 1261-694X, 3 p., HS1Article

Clinical Pharmacokinetic and Pharmacodynamic Profile of RivaroxabanMUECK, Wolfgang; STAMPFUSS, Jan; KUBITZA, Dagmar et al.Clinical pharmacokinetics. 2014, Vol 53, Num 1, pp 1-16, issn 0312-5963, 16 p.Article

Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulationCOOK-NORRIS, Robert H; MICHAELS, Jason D; WEAVER, Amy L et al.Journal of the American Academy of Dermatology. 2011, Vol 65, Num 3, pp 584-591, issn 0190-9622, 8 p.Article

Assays for Measuring Rivaroxaban: Their Suitability and LimitationsLINDHOFF-LAST, Edelgard; SAMAMA, Meyer Michel; ORTEL, Thomas L et al.Therapeutic drug monitoring. 2010, Vol 32, Num 6, pp 673-679, issn 0163-4356, 7 p.Article

Prasugrel in Clinical PracticeBHATT, Deepak L.The New England journal of medicine. 2009, Vol 361, Num 10, pp 940-942, issn 0028-4793, 3 p.Article

Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic statusIEIRI, Ichiro; KIMURA, Miyuki; IRIE, Shin et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 12, pp 851-859, issn 1744-6872, 9 p.Article

Direct Oral Anticoagulants in the Prevention of Venous Thromboembolism: Evidence From Major Clinical TrialsPRANDONI, Paolo; TEMRAZ, Sally; TAHER, Ali et al.Seminars in hematology. 2014, Vol 51, Num 2, pp 121-130, issn 0037-1963, 10 p.Article

Thromboprophylaxie pendant la grossesse et le post-partum : Anticoagulation = Antithrombotic therapy and pregnancy : Antithrombotic medicationCHAULEUR, Céline; RAIA, Tiphaine; GRIS, Jean-Christophe et al.La Presse médicale (1983). 2013, Vol 42, Num 9, pp 1251-1258, issn 0755-4982, 8 p., CAH1Article

The Management of Antithrombotic Medication in Skin SurgeryCALLAHAN, Shields; GOLDSBERRY, Anne; KIM, Glen et al.Dermatologic surgery. 2012, Vol 38, Num 9, pp 1417-1426, issn 1076-0512, 10 p.Article